Skip to content

Author

Michał Słaboszewski

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Pericoronary adipose tissue imaging biomarkers (PCAT, FAI) in normal-weight, overweight, and obese patients with CAD-RADS 0

Vascular inflammation is a key driver of atherosclerosis and plaque instability, leading to major adverse cardiac events (MACE). Although a coronary artery calcium (CAC) score of zero indicates a very low likelihood of obstructive CAD on coronary computed tomography angiography (CCTA), low-attenuation noncalcifie...

M. Słaboszewski, J. Szachowicz-Jaworska, J. Nessler et al. · 0 citations
Open access Aug 2026

Pretest DOAC removal is highly effective in lupus anticoagulant testing while on direct oral anticoagulants: a real-life experience.

BACKGROUND Direct oral anticoagulants (DOACs) may cause false-positive lupus anticoagulant (LA) results by interfering with phospholipid-dependent coagulation assays. Current guidelines discourage LA testing during DOAC therapy unless anticoagulant interference is removed. AIM To evaluate a real-life efficacy of rout...

Michał Słaboszewski, M. Ząbczyk, E. Papuga-Szela et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.